superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2020-12-31
- Valid until
- 2021-12-31
- Published
- 2021-01-26
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 11,689,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Novartis operating income: 10,152,000,000 United States dollar", as of 2020-12-31 (until 2021-12-31). Claim clm_ADC8AC894691, https://asof.is/claim/clm_ADC8AC894691, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.
APA
AsOf. (2020). Novartis operating income: 10,152,000,000 United States dollar (as of 2020-12-31 (until 2021-12-31)) [Record clm_ADC8AC894691]. Retrieved November 8, 2026, from https://asof.is/claim/clm_ADC8AC894691 (source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm)
BibTeX
@misc{asof_clm_ADC8AC894691,
author = {AsOf},
title = {Novartis operating income: 10,152,000,000 United States dollar},
year = {2020},
howpublished = {\url{https://asof.is/claim/clm_ADC8AC894691}},
note = {Claim clm\_ADC8AC894691, as of 2020-12-31 (until 2021-12-31); source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_ADC8AC894691.md/v1/claims/clm_ADC8AC894691submit a correction